Scientific Reports today published a paper describing the FLAT rapid extraction method that allows identification of bacteria and fungi in one hour. Determination of colistin resistance in Gram-negative bacteria is also demonstrated. The paper was authored by Pataigin personnel in collaboration with the labs of BACLIB inventors Prof. Robert Ernst and Prof. David Goodlett. … Continue readingPublished results: BACLIB Method IDs Pathogens and Colistin Resistance in One Hour
Pataigin Director of Development Matthew Sorensen made an oral presentation at the 2020 American Society for Mass Spectrometry conference. The subject of Sorensen’s talk was Rigel, a technology developed at Pataigin under Sorensen’s leadership for mass spectrometry-based antimicrobial susceptibility testing. … Continue readingPataigin Director Matthew Sorensen Presents Key Technology at ASMS
Professor Robert Ernst, a founder of Pataigin, has been named the 2019 University of Maryland, Baltimore Entrepreneur of the Year. Prof. Ernst is Professor and Vice Chair, Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore (UMB). This prestigious award was made in part for Ernst’s work in translating his research into Pataigin.
In 2017, Ernst was honored as UMB’s Researcher of the Year. Thus over the course of three years, Ernst has received important University awards for both basic research and transnational science. … Continue readingEntrepreneur of The Year: Pataigin Founder Prof. Robert Ernst
In a paper published in Scientific Reports, Pataigin collaborators demonstrated identification of the ESKAPE pathogens using the BACLIB method licenses by Pataigin. … Continue readingPublished results: ESKAPE pathogens identified by BACLIB
Today, at a joint meeting of the University of Maryland, Baltimore (UMB) and Johns Hopkins University, Pataigin was awarded a $25,000 Maryland Department of Commerce Life award for Pataigin’s application of lipid fingerprint technology licensed from UMB. Pataigin has developed a test, called BACLIB, that inexpensively identifies bacteria and fungi causing infections in less than an hour. Pataigin plans on using its award funding to validate tests for high-priority antibiotic-resistant microbes such as ESKAPE pathogens. … Continue readingPataigin Wins Innovation Award
The University of Maryland, Baltimore (UMB) has granted Pataigin worldwide, exclusive licensing rights to UMB patents and technology for a method to quickly and accurately identify dangerous pathogens. Robert Ernst, Ph.D., associate professor of microbial pathogenesis at UMB School of Dentistry, and David Goodlett, Ph.D., professor of pharmaceutical sciences at UMB School of Pharmacy, are patent inventors. The University of Washington is also a co-owner on one of the patents. Erik Nilsson, who has headed software and mass spectrometry companies for nearly 20 years, will serve as Pataigin’s CEO. … Continue readingPataigin Granted Exclusive Rights to Lipid Fingerprint Technology